TSXV:BTI.H - Post by User
Comment by
MineDiggeron Jun 15, 2022 3:21am
144 Views
Post# 34757159
RE:(TSXV:BTI.V; OTCQB:BIOAF): 4th Quarter/YE Statements
RE:(TSXV:BTI.V; OTCQB:BIOAF): 4th Quarter/YE StatementsI see no new positive information in the MD&A (YE to 2022-02-28), have I missed anything? No obvious comment about any ongoing collaborations, but I haven't read every word. It is said "no news is good news" wrt Bioasis I disagree. In fact, they’ve even fallen out with two partners it seems “two contract dispute matters". Is it possible our valuable know-how is being stolen by one or two of the so-called partners? Or did Bioasis screw up? Or what?
No cash: "its existing cash balance is sufficient to fund operation through approximately July 2022" There is mention of $7m remaining of the Lind $10m , but nothing said about intending to use it.
Next to no income, just $38k in Q3: "The increase in research revenue of $37,725 from YTD Q4 2021 to YTD Q4 2022, is due to a new material transfer agreement with a global pharmaceutical company in Q3 2022, as compared to an absence of new material agreements in YTD Q4 2021.". Whatever that was it isn’t worth investigating.
As I said, didn’t read every word and I haven’t finished my first espresso, but I’m not seeing any new positives, at all.
MD